| EDB503-Tecniques of Article Writing | 3 | 3 | 2 | 3 | 3 | 2 | 1 | 2 | 3 | 1 | 3 | 2 |
| FKL502-Neurohumoral Interactions | 3 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 1 | 2 |
| FKL505-Peptidergic Mechanisms | 3 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 3 | 2 | 3 | 3 |
| FKL512-Receptors, Signal Transuduction and Drug Action | 3 | 2 | 1 | 1 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 2 |
| FKL516-Application of Molecular Biological Methods in Pharmacology | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |
| FKL520-Behavioral Pharmacology | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |
| FKL522-Economy of Drugs | | | | | | | | | | | | |
| FKL523-Experimental Pharmacology I | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| FKL525-Ion Channels Pharmacology | 3 | 1 | 2 | 2 | 3 | 3 | 0 | 1 | 2 | 3 | 2 | 0 |
| FKL526-Introduction to Nervous System | | | | | | | | | | | | |
| FKL527-Cancer Pharmacology | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |
| FKL529-Pharmacogenetic | 3 | 3 | 2 | 2 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |
| FKL530-Autocoids | | | | | | | | | | | | |
| FKL531-Receptor Theories and Experimental Application | 3 | 1 | 3 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 1 |
| FKL532-Ethnopharmacology | 2 | 2 | 3 | 3 | 1 | 2 | 2 | 2 | 3 | 2 | 2 | 3 |
| FKL534-Pharmacology of Aautonomic Nervous System | | | | | | | | | | | | |
| FKL538-Pharmaceutical Biophysics | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| FKL540-Pharmacotherapy of Drug and Substance Addiction | 3 | 1 | 3 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 1 |
| FKL547-Pharmacotherapy | 3 | 0 | 2 | 0 | 3 | 3 | 0 | 2 | 3 | 3 | 3 | 0 |
| FKL549-Rational Drug Use | | | | | | | | | | | | |
| FKL551-Structural Neuropharmacology | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 |
| SMR500-Seminar | | | | | | | | | | | | |
| TEZ700-Thesis | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| UZM700-Research in Area of Specialization | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |